These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 374755

  • 21. The pattern of excess cancer in dialysis and transplantation.
    Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR.
    Nephrol Dial Transplant; 2009 Oct; 24(10):3225-31. PubMed ID: 19589786
    [Abstract] [Full Text] [Related]

  • 22. [Tumors and kidney transplantation].
    Brünisholz M, Hodel K, Brunner FP, Harder F, Torhorst J, Thiel G.
    Schweiz Med Wochenschr; 1984 Dec 22; 114(51):1915-24. PubMed ID: 6395328
    [Abstract] [Full Text] [Related]

  • 23. [REIN Report 2011--summary].
    Couchoud C, Lassalle M, Jacquelinet C.
    Nephrol Ther; 2013 Sep 22; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [Abstract] [Full Text] [Related]

  • 24. Malignancy after renal transplantation: a single-center experience.
    Vrotniakaite K, Jaceviciute R, Rudminiene I, Laucyte-Cibulskiene A, Rainiene T, Jankevicius F, Zelvys A, Miglinas M.
    Ann Transplant; 2014 Sep 15; 19():456-63. PubMed ID: 25223375
    [Abstract] [Full Text] [Related]

  • 25. The risk of ano-genital malignancies in dialysis and transplant patients.
    Fairley CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG, Amiss N.
    Clin Nephrol; 1994 Feb 15; 41(2):101-5. PubMed ID: 8004825
    [Abstract] [Full Text] [Related]

  • 26. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H, Walschburger-Zorn K, Häberle L, Wach S, Engehausen DG, Wullich B.
    Clin Transplant; 2013 Feb 15; 27(1):E30-6. PubMed ID: 23278453
    [Abstract] [Full Text] [Related]

  • 27. Malignancy after kidney transplantation: still a challenge.
    Bosmans JL, Verpooten GA.
    Kidney Int; 2007 Jun 15; 71(12):1197-9. PubMed ID: 17554350
    [Abstract] [Full Text] [Related]

  • 28. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.
    Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, Jauch KW, Guba M.
    Kidney Int; 2007 Jun 15; 71(12):1271-8. PubMed ID: 17332737
    [Abstract] [Full Text] [Related]

  • 29. [Uremic osteopathy in dialysis and transplantation with reference to bone scanning].
    Bahlmann J, Gisbertz A, Creutzig H, Vykoupil K.
    Verh Dtsch Ges Inn Med; 1974 Jun 15; 80():736-8. PubMed ID: 4616509
    [No Abstract] [Full Text] [Related]

  • 30. [Costs of care in uremia. How much does kidney transplantation cost?].
    Jakobsen A, Albrechtsen D, Sødal G, Flatmark A, Fauchald P, Vartdal F.
    Tidsskr Nor Laegeforen; 1990 Jan 30; 110(3):338-41. PubMed ID: 2309175
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
    Montagnino G, Lorca E, Tarantino A, Bencini P, Aroldi A, Cesana B, Braga M, Lonati F, Ponticelli C.
    Clin Transplant; 1996 Oct 30; 10(5):461-9. PubMed ID: 8930463
    [Abstract] [Full Text] [Related]

  • 33. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
    Opelz G, Unterrainer C, Süsal C, Döhler B.
    Nephrol Dial Transplant; 2016 Aug 30; 31(8):1360-7. PubMed ID: 27190384
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Renal Tumor in Allogeneic Kidney Transplant Recipient.
    Bieniasz M, Chmura A, Kwapisz M, Czerwińska M, Kieszek R, Domagała P, Wszoła M, Serwańska-Świętek M, Górnicka B, Durlik M, Pączek L, Kwiatkowski A.
    Transplant Proc; 2016 Jun 30; 48(5):1849-54. PubMed ID: 27496506
    [Abstract] [Full Text] [Related]

  • 38. Malignancy after renal transplantation in the new era of immunosuppression.
    Watorek E, Boratynska M, Smolska D, Patrzalek D, Klinger M.
    Ann Transplant; 2011 Jun 30; 16(2):14-8. PubMed ID: 21716180
    [Abstract] [Full Text] [Related]

  • 39. Management of uremia in older patients: hemodialysis and renal transplantation.
    Figueroa JE.
    J Am Geriatr Soc; 1968 Dec 30; 16(12):1323-30. PubMed ID: 4880683
    [No Abstract] [Full Text] [Related]

  • 40. The nitroblue-tetrazolium test. Usefulness in detecting bacterial infections in uraemic and immunosuppressed renal transplant patients.
    Wollman MR, David DS, Brennan BL, Lewy JE, Stenzel KH, Rubin AL, Miller DR.
    Lancet; 1972 Aug 12; 2(7772):289-91. PubMed ID: 4115028
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.